Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:BDX
Becton Dickinson and Co
|
234.68 | 16.24% | 30.46% | 67,799.58 | 1.58% | 2.09% |
|
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
|
1511.15 | -17.18% | -5.3% | 3,625,755.04 | 0.82% | 24.54% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
13.98 | -37.32% | -33.28% | 15,834.32 | 0% | -2.6% |
|
NSEI:CIPLA
Cipla
|
1424.75 | 9.62% | 22.24% | 1,130,313.89 | 0.6% | 14.64% |
|
NSEI:ZYDUSLIFE
Zydus Lifesciences
|
997.40 | -32.53% | -27.56% | 959,494.42 | 0.61% | 6.43% |
|
SEHK:1093
CSPC Pharmaceutical Group
|
6.76 | 37.88% | 54.6% | 76,753.21 | 4.17% | 19.3% |
|
NSEI:ALKEM
Alkem Laboratories
|
4904.00 | -9.14% | 8.35% | 577,863.62 | 0.52% | 11.01% |
|
NSEI:NATCOPHARM
NATCO Pharma
|
1034.10 | 60.91% | 97.07% | 182,360.71 | 0.94% | 0.03% |
|
TPEX:4105
TTY Biopharm Company
|
77.60 | 41.96% | 70.83% | 19,295.24 | 4.51% | -5.05% |
|
OTCPK:NWBO
Northwest Biotherapeutics
|
0.46 | 0% | 0% | 560.52 | 0% | 0% |
|
NasdaqGM:FATE
Fate Therapeutics
|
4.06 | 0% | 0% | 462.1 | 0% | 0% |
|
NasdaqCM:CAPR
Capricor Therapeutics
|
5.47 | 0% | 0% | 183.46 | 0% | 0% |
|
NasdaqCM:FBIO
Fortress Biotech
|
1.75 | 0% | 0% | 33.66 | 0% | 0% |
|
NasdaqCM:PIRS
Pieris Pharmaceuticals
|
11.08 | 0% | 0% | 14.35 | 0% | 0% |
|
NasdaqCM:ONTX
Onconova Therapeutics
|
0.68 | 0% | 0% | 13.75 | 0% | 0% |
|
NasdaqCM:BRTX
BioRestorative Therapies
|
1.37 | 0% | 0% | 9.27 | 0% | 0% |
|
NasdaqCM:CYCC
Cyclacel Pharmaceuticals
|
2.00 | 0% | 0% | 3.49 | 0% | 0% |
|
BSE:524689
Parenteral Drugs (India)
|
5.41 | 0% | 0% | 132.09 | 0% | 0% |
|
OTCPK:VRAY.Q
ViewRay
|
0.00 | 0% | 0% | 0.02 | 0% | 0% |
